These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32829961)

  • 1. Understanding the andromeda strain - The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness.
    Mir N; D'Amico A; Dasher J; Tolwani A; Valentine V
    Blood Rev; 2021 Jan; 45():100731. PubMed ID: 32829961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulopathy in COVID-19: Focus on vascular thrombotic events.
    Shi W; Lv J; Lin L
    J Mol Cell Cardiol; 2020 Sep; 146():32-40. PubMed ID: 32681845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and Hypercoagulability.
    Sholzberg M
    Clin Adv Hematol Oncol; 2020 Jul; 18(7):386-389. PubMed ID: 32903249
    [No Abstract]   [Full Text] [Related]  

  • 4. Thromboembolic events and Covid-19.
    Ribes A; Vardon-Bounes F; Mémier V; Poette M; Au-Duong J; Garcia C; Minville V; Sié P; Bura-Rivière A; Voisin S; Payrastre B
    Adv Biol Regul; 2020 Aug; 77():100735. PubMed ID: 32773098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?
    Tal S; Spectre G; Kornowski R; Perl L
    Acta Haematol; 2020; 143(5):417-424. PubMed ID: 32396903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 coagulopathy: An in-depth analysis of the coagulation system.
    Martín-Rojas RM; Pérez-Rus G; Delgado-Pinos VE; Domingo-González A; Regalado-Artamendi I; Alba-Urdiales N; Demelo-Rodríguez P; Monsalvo S; Rodríguez-Macías G; Ballesteros M; Osorio-Prendes S; Díez-Martín JL; Pascual Izquierdo C
    Eur J Haematol; 2020 Dec; 105(6):741-750. PubMed ID: 32749010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
    Eljilany I; Elzouki AN
    Vasc Health Risk Manag; 2020; 16():455-462. PubMed ID: 33223833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory biomarkers and prognosis in Covid-19, where do we stand?
    Israni A; Goulden CJ; Harky A
    Rev Med Virol; 2021 Nov; 31(6):e2296. PubMed ID: 34516018
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19-associated coagulopathy and disseminated intravascular coagulation.
    Asakura H; Ogawa H
    Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombocytopathy vs Platelet hyper-reactivity in COVID-19: diverse pathologies, disease outcomes and therapeutic implications.
    Tafazoli A; Anil Kumar S; Othman M
    Platelets; 2022 Jan; 33(1):48-53. PubMed ID: 34847829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action.
    Kollias A; Kyriakoulis KG; Dimakakos E; Poulakou G; Stergiou GS; Syrigos K
    Br J Haematol; 2020 Jun; 189(5):846-847. PubMed ID: 32304577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2: What is known and what there is to know-Focus on coagulation and lipids.
    Carbone F; Montecucco F; Twickler M
    Eur J Clin Invest; 2020 Jul; 50(7):e13311. PubMed ID: 32511751
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement activation and coagulopathy - an ominous duo in COVID19.
    Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
    Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
    Miesbach W; Makris M
    Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection.
    Pooni RS
    Clin Med (Lond); 2020 Jul; 20(4):e59. PubMed ID: 32675158
    [No Abstract]   [Full Text] [Related]  

  • 16. Hematological findings and complications of COVID-19.
    Terpos E; Ntanasis-Stathopoulos I; Elalamy I; Kastritis E; Sergentanis TN; Politou M; Psaltopoulou T; Gerotziafas G; Dimopoulos MA
    Am J Hematol; 2020 Jul; 95(7):834-847. PubMed ID: 32282949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic Complications of COVID-19 Infection: A Review.
    Castro RA; Frishman WH
    Cardiol Rev; 2021; 29(1):43-47. PubMed ID: 32947478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review of the prognostic utility of D-dimer, disseminated intravascular coagulation, and anticoagulant therapy in COVID-19 critically ill patients.
    Moreno G; Carbonell R; Bodí M; Rodríguez A
    Med Intensiva (Engl Ed); 2021; 45(1):42-55. PubMed ID: 32646669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness.
    Lippi G; Henry BM; Sanchis-Gomar F
    Semin Thromb Hemost; 2021 Jun; 47(4):460-462. PubMed ID: 33378783
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytokine Storm: Is it the only major death factor in COVID-19 patients? Coagulation role.
    Magro G
    Med Hypotheses; 2020 Sep; 142():109829. PubMed ID: 32428809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.